Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Hokey

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Human Vaccines & Immunotherapeutics|July 1, 2015
Tuberculosis vaccine development: Shifting focus amid increasing development challengesA J Graves, D A Hokey
Vaccine|May 5, 2015
A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infantsM Tameris, D A Hokey, V Nduba, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Human Vaccines & Immunotherapeutics|July 1, 2015
Tuberculosis vaccine development: Shifting focus amid increasing development challengesA J Graves, D A Hokey
Vaccine|May 5, 2015
A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infantsM Tameris, D A Hokey, V Nduba, et al.
Pageof 1